Bacteroides thetaiotaomicron, an obligate anaerobe found in high numbers in human colons, can utilize a variety of polysaccharides. To determine which type of polysaccharide contributes most to the nutrition of B. thetaiotaomicron in vivo, we isolated and characterized transposon-generated mutants deficient in the ability to use different polysaccharides. Some mutants were deficient in polysaccharide utilization because of the inability to utilize a component monosaccharide. These mutants included a mutant that was unable to utilize L-fucose (a component of goblet cell mucin), a mutant that was unable to utilize D-galactose (a component of raffinose, stachyose, arabinogalactan, and goblet cell mucin), and a mutant that was unable to utilize either glucuronic acid (a component of mucopolysaccharides) or galacturonic acid (a component of polygalacturonic acid or pectin). Other mutants were unable to use the polysaccharide but could use the component sugars. These included four mutants that were unable to utilize starch and one mutant that was unable to utilize polygalacturonic acid. The mutants were tested for the ability to compete with the wild type for colonization of the intestinal tracts of germfree mice. The only mutants against which the wild type competed successfully in the intestinal tracts of germfree mice were a galactose-negative mutant and a uronic acid-negative mutant. These mutations differed from the others tested in that they affected utilization of more than one type of polysaccharide. This result is consistent with the hypothesis that B. thetaiotaomicron is a scavenger which is highly adapted for utilization of small amounts of a variety of carbohydrates and is thus able to sustain loss of the ability to utilize a single type of polysaccharide without significant lowering of its ability to survive in intestinal tracts.
Bacteroides thetaiotaomicron, an obligate anaerobe found in high numbers in human colons, can utilize a variety of polysaccharides. To determine which type of polysaccharide contributes most to the nutrition of B. thetaiotaomicron in vivo, we isolated and characterized transposon-generated mutants deficient in the ability to use different polysaccharides. Some mutants were deficient in polysaccharide utilization because of the inability to utilize a component monosaccharide. These mutants included a mutant that was unable to utilize L-fucose (a component of goblet cell mucin), a mutant that was unable to utilize D-galactose (a component of raffinose, stachyose, arabinogalactan, and goblet cell mucin), and a mutant that was unable to utilize either glucuronic acid (a component of mucopolysaccharides) or galacturonic acid (a component of polygalacturonic acid or pectin). Other mutants were unable to use the polysaccharide but could use the component sugars. These included four mutants that were unable to utilize starch and one mutant that was unable to utilize polygalacturonic acid. The mutants were tested for the ability to compete with the wild type for colonization of the intestinal tracts of germfree mice. The only mutants against which the wild type competed successfully in the intestinal tracts of germfree mice were a galactose-negative mutant and a uronic acid-negative mutant. These mutations differed from the others tested in that they affected utilization of more than one type of polysaccharide. This result is consistent with the hypothesis that B. thetaiotaomicron is a scavenger which is highly adapted for utilization of small amounts of a variety of carbohydrates and is thus able to sustain loss of the ability to utilize a single type of polysaccharide without significant lowering of its ability to survive in intestinal tracts.
Bacteroides spp. are gram-negative obligate anaerobes found in high numbers in the resident microflora of human colons (7) . Some species of human colonic Bacteroides spp. are notable for the ability to ferment a variety of polysaccharides, including not only polysaccharides from the host's diet but also polysaccharides produced by the host itself (10) . Presumably this versatility contributes to survival in a colon, where a complex mixture of carbohydrates confronts the resident bacteria. But no attempt has been made to test the importance of different polysaccharide utilization pathways in vivo. One approach is to test the abilities of mutants deficient in the utilization of individual polysaccharides to colonize the intestinal tracts of germfree mice.
Recently, we showed that two of three mutants deficient in the utilization of the host mucopolysaccharide chondroitin sulfate were competed against successfully by the wild type when mice were colonized with a mixture of wild-type and mutant bacteria (9). This finding could be interpreted to support the hypothesis that chondroitin sulfate contributes to the survival of Bacteroides spp. in intestines. However, there were two reasons to doubt this interpretation. (i) Although one of the chondroitin sulfate-negative mutants was competed against successfully by the wild type, another with a similar phenotype was not. Neither mutation appeared to affect growth on other carbohydrates (9), but we could not rule out the possibility that the chondroitin sulfatenegative mutant which was competed against successfully by the wild type carried a mutation that affected pathways other than that involved in chondroitin sulfate utilization. (ii) The mutant most rapidly outcompeted by the wild type was * Corresponding author. unable to use chondroitin sulfate because it was unable to use one of the component sugars, N-acetylgalactosamine. Since N-acetylgalactosamine is also a component of glycoprotein mucin secreted by intestinal goblet cells (15) , this mutant might also be deficient in the ability to utilize goblet cell mucin.
Before any conclusions can be made about the importance, relative to other polysaccharides, of chondroitin sulfate as a carbon source in intestinal tracts, it is necessary to know how mutations that disrupt other polysaccharide utilization systems of B. thetaiotaomicron might affect the survival of the organism in germfree intestinal tracts. B. thetaiotaomicron can utilize a number of dietary polysaccharides that might be encountered in animals, including starch, polygalacturonic acid, arabinogalactan, and raffinose. Thus, we wanted to determine whether mutants deficient in the ability to utilize these dietary polysaccharides would be competed against successfully by the wild type in germfree mice.
In addition, the possibility that goblet cell mucin serves as a substrate needs to be assessed. Mammalian goblet cell mucin is not commercially available. Thus, it is not possible to determine by a direct test whether B. thetaiotaomicron can degrade goblet cell mucin. However, B. thetaiotaomicron can utilize the four main components of goblet cell mucin, N-acetylglucosamine, N-acetylgalactosamine, galactose, and fucose (10, 15) . Utilization of sialic acid, another component of mucin, has not been tested. One way to determine whether goblet cell mucin is a carbohydrate source for B. thetaiotaomicron in intestines would be to (2) . For characterization of the mutants, we used a defined medium (5, 13) to which various carbohydrate sources were added. Glucose, D-arabinose, L-arabinose, L-fucose, L-xylose, L-rhamnose, D-galactose, D-glucuronic acid, D-galacturonic acid, melibiose, maltose, and maltoheptose (G7) were filter sterilized and added to the medium after being autoclaved. Arabinogalactan, polygalacturonic acid, chondroitin sulfate (type II), amylose, and amylopectin were autoclaved in the medium. All carbohydrates were obtained from Sigma Chemical Co., St. Louis, Mo. The gas phase of liquid medium was 80% nitrogen-20% carbon dioxide. Plates used in the mutagenesis experiments and for isolation of colonies were incubated in GasPak jars (BBL).
Isolation and characterization of mutants. All of the mutants used in this study were obtained by mutagenesis of B. thetaiotaomicron with Tn4351. The mutagenesis protocol has been described previously (12) . The characteristics of the mutants used in this study are listed in Table 1 . For all of the Tn4351-generated mutants except one, we were able to obtain Ems derivatives of the original Emr transposon insertion by screening several thousand colonies for Ems. Ems derivatives occur as a result of recombination between the direct-repeat insertion sequence elements that flank Tn4351 (12) . With the one exception, PG-2, we were unable to obtain an Ems version of this mutant, despite several attempts. Accordingly, we used the strain with the full Tn4351 insertion. Since Tn4351 often cointegrates R751, the plasmid which is used to move it into B. thetaiotaomicron, we screened each mutant for R751 DNA by colony hybridization, as described previously, with labeled R751 as the probe (8, 9 ). The strains that had R751 cointegrated in the chromosome are indicated in Table 1 as IS::R751. Mutants were tested for reversion to the wild type as described previously (9).
To ascertain that the mutations did not have a general effect on growth rate, the growth rate of each mutant was determined in glucose defined medium and compared with that of the wild type. If the growth rates were identical by this test, a more sensitive competition assay was used. Equal numbers of mutant and wild-type bacteria were inoculated into glucose defined medium. Once the mixture had grown to an optical density (600 nm) of about 1.0, 0.05 ml was inoculated into a fresh 10-ml tube of glucose defined medium. This process was repeated four times for a total of about 50 generations. Appropriate dilutions of the mixtures were plated, and 80 isolated colonies were screened to ascertain the percentage of wild-type organisms.
The mutants that were unable to use a monosaccharide were tested for sensitivity to the monosaccharide. A carbohydrate other than glucose was used as the growth substrate to avoid glucose-mediated exclusion of the monosaccharide being tested. Galactose-negative mutant AG-4 was inoculated into medium containing polygalacturonic acid (0.5%) and galactose (0.5%), and the growth rate was compared with that of the mutant in medium containing polygalacturonic acid alone. The fucose-negative mutants and the uronic acid-negative mutant PG-2 were tested similarly in medium containing arabinogalactan (0.5%) and either fucose (0.5%) or galacturonic acid (0.5%). Some types of galactose-negative mutants have altered lipopolysaccharide. This often results in heightened susceptibility to antibiotics because of disruption of the outer membrane. Accordingly, we tested the galactose-negative mutant for increased susceptibility to antibiotics by spreading 0.1 ml of a mid-exponential-phase culture of bacteria on a TYG plate and placing disks containing ampicillin, chloramphenicol, and erythromycin on the plate. After incubation at 37°C for 48 h, the diameter of the clear zone surrounding each disk was measured and compared with the zone diameter obtained with the wild type. Zones were considered to be identical if they differed by 2 mm or less.
To determine whether the fucose-negative mutants were deficient in uptake of L-fucose, we tested their abilities to take up L-[6-3H]-fucose (70 Ci/mmol; Amersham Corp., Arlington Heights, Ill.). Cells were grown in L-rhamnose defined medium. Since L-rhamnose shares part of the catabolic pathway used by L-fucose, it might act as an inducer of L-fucose permease. At the very least, it should not interfere with L-fucose uptake by repressing synthesis of the permease or by exclusion of L-fucose. When the 10-ml cultures VOL. 55, 1989 on August 14, 2017 by guest http://aem.asm.org/ Downloaded from reached an optical density (600 nm) of 0.5 to 0.6, they were harvested by centrifugation (27,000 x g, 25°C) and suspended in 5 ml of 50 mM potassium phosphate buffer, pH 7.0. Sitspended cells were equilibrated at 37°C for 5 min, and 1 ml *ds added to a tube containing 0.1 ml of labeled L-fucose to start uptake. The final concentration of L-fucose was 5 ,uM (2 ,uCi/ml). Portions (0.2 ml) of the mixture were taken at intervals, placed on nitrocellulose filters, and washed with 15 ml of phosphate buffer (37°C). The filters were air dried and counted in ACS scintillation fluid (Amersham).
Germfree mouse experiments. Germfree BALB/c mice were purchased from the Gnotobiotic Laboratory, University of Wisconsin, Madison. Procedures for maintaining mice and testing them for sterility have been described previously (8, 16 fucose-negative mutants are shown in Fig. 1 . Neither of these mutants was competed against successfully by the wild type. Similar result were obtained with the starch-negative mutants ( Fig. 2 and 3) . None of the starch-negative mutants was competed against successfully by the wild type, although in some cases the percentage of wild-type bacteria increased during the first several days of the competition before levelling off. For MS-1, we used the original Tn4351 insertion as well as the Ems derivative in competition experiments to determine whether Emr itself would have any effect on the outcome. The results indicated that the presence of the gene for Emr did not affect the competition (Fig.  2) .
Results of competitions involving the two polygalacturonic acid-negative mutants PG-2 and PG-4 are shown in Fig.  4 . PG-2 was successfully competed against initially by the wild type, but the mutant began to reappear after about 14 days. This same result was seen in replicate experiments. In the competition involving PG-4, the percentage of wild-type bacteria rose above the initial level but never reached 100%. Thus, the PG-4 mutation was not as deleterious as the PG-2 mutation, although the PG-4 mutation appeared to be somewhat deleterious during the initial competition period.
The most deleterious mutation was the mutation in AG-4. This galactose-negative mutant was successfully competed against by the wild type within 2 to 5 days (Fig. 5) . Unlike PG-2, the mutant was not detected in any samples after the wild type reached 100%. All of the mutants were checked by Southern blot analysis of chromosomal DNA to ascertain that there was only one insertion in the chromosome. In AG-4, Southern analysis revealed that the Ems derivative contained two insertion sequences, whereas a similar analysis of the original transposon insertion showed that there was only one insertion of Tn4351 (data not shown). Accordingly, we did competition experiments using the original Tn4351 insertion as well as the Ems derivative to confirm that the outcome of the competition between the wild-type and Ems strains was not influenced by the extra insertion sequence. The results were the same regardless of which version of the mutant was used (Fig. 5 ).
DISCUSSION
In two recent studies of polysaccharidase activities in human feces, we attempted to determine whether enzymes that are normally induced during growth of Bacteroides spp. on starch or polygalacturonic acid are produced at fully induced levels in human colons. We found no evidence for induction in vivo of Bacteroides enzymes associated with utilization of either of these polysaccharides (4, 5) . These findings indicated that neither starch nor polygalacturonic acid is utilized by bacteria in the human colon at levels high enough to induce the polysaccharidases. One explanation of these findings is that colonic Bacteroides spp. rely mainly on some type of polysaccharide other than starch and polygalacturonic acid for carbon and energy. An alternative expla- MS-2 and MS-4 differ from MS-1 in that they produce enzymes associated with starch breakdown when they are grown on maltose, whereas MS-1 does not produce any of the starch-associated enzymes under similar conditions (1). The procedure used for the competition experiments is described in the legend to Fig. 1 . nation is that Bacteroides spp. do not rely primarily on any single polysaccharide when growing in a colon but rather use small amounts of a variety of polysaccharides. When Bacteroides spp. grow in laboratory medium with a single polysaccharide as the sole source of carbon and energy, enzyme specific activities usually rise more than 20-fold above the uninduced levels (4, 5) . However, if bacteria in the colon use only small amounts of any particular polysaccharide and utilize more than one polysaccharide at a time, the rise in enzyme specific activities could be relatively small. In our earlier studies of enzyme activities in human colon contents, we would probably not have detected increases in enzyme activity unless they were at least 5-to 10-fold above the uninduced levels. Thus, the results of these studies could not rule out either the hypothesis that Bacteroides spp. utilize small amounts of a variety of polysaccharides in colons or the hypothesis that Bacteroides spp. in colons rely mainly on polysaccharides other than starch and polygalacturonic acid.
Accordingly, in the current study, we used a different approach to determine what polysaccharide sources are important for Bacteroides spp. growing in an intestinal tract. We used germfree mice as a simple model system to assess the consequences of losing the ability to utilize each of the polysaccharides known to be fermented by B. thetaiotaomicron. If B. thetaiotaomicron relies primarily on one or two types of polysaccharide in vivo, mutations that affect utilization of these particular polysaccharides should be deleterious, whereas mutations that affect utilization of other PG-2 differed from PG-4 in that it was unable to grow on either galacturonic or glucuronic acid, whereas PG-4 could utilize both monosaccharides. PG-2, unlike PG-4, was deficient in the ability to grow on chondroitin sulfate. Both grew the same as the wild type on all of the other carbohydrates tested. The procedure used is described in the legend to Fig. 1. polysaccharides should have no effect. By contrast, if B. thetaiotaomicron uses small amounts of a variety of polysaccharides in germfree intestinal tracts, mutations that interfere with utilization of any single type of polysaccharide might not have a drastic effect on competitiveness because the organism has many alternate carbohydrate sources. Rather, it should be necessary to eliminate utilization of more than one type of polysaccharide before loss of competitiveness was detectable. The results of the experiments reported here support the hypothesis that B. thetaiotaomicron uses small amounts of a variety of polysaccharides in vivo rather than relying primarily on one or two main carbohydrate sources, because the mutations that were most deleterious were those that affected utilization of more than one polysaccharide, i.e., the mutations in PG-2 and AG-4. Fig. 1 . In two experiments, the original Tn4351 insertion mutant was used (Tn), and in two other experiments, the Ems derivative (IS) was used in the competition.
The results of competitions involving four different types of starch-negative mutants showed that none of these mutants was competed against successfully by the wild type. Thus, loss of the ability to utilize starch had no detectable effect on competitiveness. This does not rule out the possibility that these mutations would be more deleterious if other organisms besides B. thetaiotaomicron had been present, but we can conclude that these mutations were less deleterious than the mutations in AG-4 and PG-2. The relative unimportance of starch as a substrate could reflect the fact that when animals are fed a conventional chow diet, only low levels of starch enter the colon. A diet high in retrograded starch, a form of starch that is not readily degraded in small intestines, might cause starch-negative mutants to be less competitive.
Our finding that both fucose-negative mutants competed equally with the wild type indicates that glycoprotein mucins are not a major source of carbohydrate for bacteria growing in the intestines of mice fed a chow diet. We thought that mucin would be a possible substrate because it is a major component of material entering the colon and appears to be degraded extensively during passage through a colon (14) . Some colonic bacteria can ferment hog gastric mucin and bovine submaxillary mucin (6) . Hog gastric mucin and bovine submaxillary mucin were not fermented extensively enough by most of the human colonic Bacteroides strains to be scored as a growth substrate in a previous survey of polysaccharide utilization by these organisms (10) . How Although human goblet cell mucin is not commercially available and thus cannot be used to test the effect of the fucose-negative mutation directly, we expected that this mutation should affect mucin utilization because fucose accounts for about 20% of the carbohydrate in goblet cell mucin (15) . Goblet cell mucin of rodents is similar in composition to that of humans, and studies of mucin secretion in animals have shown that although the amount of mucin secreted may vary with diet, the composition does not (11, 15 
